Hepatic recompensation according to Baveno VII criteria significantly reduces liver-related mortality in patients with decompensated alcohol-related cirrhosis
Benedikt Hofer(Austrian Academy of Sciences), Thomas Reiberger(ERN GUARD-Heart), Lukas Hartl(Medical University of Vienna), Bernhard Scheiner(Medical University of Vienna), Rafael Paternostro(Medical University of Vienna), Georg Semmler(University of Southern Denmark), Albert Friedrich Stättermayer(Medical University of Vienna), Mathias Jachs(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Lorenz Balcar(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Philipp Schwabl(Austrian Academy of Sciences), Benedikt Simbrunner(Austrian Academy of Sciences)
Cited by 2
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561